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lytic myofibers (IIb + IIx), and an overall decrease in capillary density was observed in
CSQ/CHF mice compared to WT littermates. Analysis of fiber type-specific capillary den-
sity revealed an increase in type IIa myofiber capillary density and a concomitant
decrease in type IIb + IIx myofiber capillary density in the CSQ/CHF mice. Conclusion.
These results suggest that chronic heart failure causes skeletal muscle fiber type switch-
ing and dysregulation of angiogenesis in a fiber type-specific manner. Furthermore,
these results support the use of the CSQ/CHF mouse model to further study the role of
skeletal muscle maladaptation in chronic heart failure and to explore potential therapeutic
targets.
1045-197 Evidence for Hypoxia and Hypoxia-Inducible Factor-1-
Alpha Mediated Vascular Endothelial Growth Factor 
Expression in Lipid-Rich Plaque Macrophages as Link 
Between Inflammation and Angiogenesis
Randolph Hutter, Carolina Valdiviezo, Bernhard Sauter, Roberto Corti, Gurusher 
Panjrath, Francine Carrick, John T. Fallon, Valentin Fuster, Juan Jose Badimon, Mount 
Sinai School of Medicine, New York, NY
Background: Macrophages expressing the pro-angiogenic factor VEGF can contribute to
plaque progression and vulnerability via induction of intimal neovascularization. Hypoxia
Inducible Factor 1-alpha (HIF-1 alpha) has been identified as key transcriptional regulator
of cellular VEGF-synthesis and mediates the angiogenic response of tissues to hypoxia.
However, little is known about the pattern of expression of HIF-1 alpha in atherosclerosis.
Our objective was to assess in parallel the expression of HIF-1 alpha and VEGF in
human and experimental atherosclerosis comparing lipid-rich with fibrous plaque.
Methods: In human atheroma (n=12) HIF-1 alpha and VEGF mRNA and protein expres-
sion were evaluated by in situ hybridization and immunohistochemistry (data presented
as mean±SEM). In NZW-rabbits (n=14) atherosclerotic lesions were induced by aortic
double balloon injury and 9 months of high-cholesterol (HC) diet. Five rabbits were sacri-
ficed at 9 months and were used as baseline (BL). The remaining rabbits were then ran-
domized into continued HC diet (n=5) and normal chow diet (ND) (n=4) for another 6
months. Total serum cholesterol at the end of ND treatment was 27±10 mg/dl vs.
861±143 mg/dl at BL (P<.01) and 526±108 mg/dl with continued HC-diet at 15 months
(P<.01).
Results: In human atheroma, HIF-1 alpha and VEGF mRNA and protein expression were
increased in lipid-rich compared to fibrous plaque (23±5 % vs. 5±2 %, P<.01; 32±6 % vs.
8±3 %, P<.05) and correlated with high macrophage and neovessel content (P<.05).
Double-labeling demonstrated co-localization of HIF-1 alpha and VEGF in inflammatory
cells surrounding intimal neovessels in close proximity to cholesterol clefts. In plaques of
rabbits with continued HC diet and high serum lipid levels expression of both HIF-1 alpha
and VEGF-protein as assessed by immunohistochemistry and Western Blot were signifi-
cantly increased compared to BL and ND.
Conclusions: The selective detection of HIF-1 alpha in VEGF-expressing macrophages
located in lipid-rich plaque tissue points to hypoxia as a possible link between inflamma-
tion and angiogenesis. Both processes might synergistically contribute to plaque pro-
gression and vulnerability.
1045-198 Influence of Diabetes Mellitus on Coronary Collateral 
Flow: A Definite Answer to a Rather Elderly Controversy
Rainer Zbinden, Stefan Zbinden, Michael Billinger, Stefan Windecker, Bernhard Meier, 
Christian Seiler, Cardiovascular Center Bern, Bern, Switzerland
Background: The influence of diabetes mellitus (DM) on coronary collateral flow is con-
troversial. This may be due to the use of inaccurate means of measuring collateral flow
(i.e. angiographic assessment), another reason relates to differences in parameters influ-
encing collateral flow between diabetic and nondiabetic patients (serum lipids, severity of
coronary artery disease (CAD)). The purpose of this study was to determine the influ-
ence of DM on coronary collateral flow in a large population with variable degrees of CAD
using accurate means of collateral flow measurement.
Methods: 187 patients (age 63 +/- 9 years; 86 diabetic and 101 nondiabetic patients)
were included in the study. Coronary collateral flow was assessed in 196 stenotic and in
38 angiographically normal vessels using a pressure guide wire (n=145), Doppler guide
wire (n=53) or both (n=36) to calculate pressure- or flow-velocity-derived collateral flow
index (CFI). Diabetic patients were matched for gender, age, serum lipids and percent
diameter stenosis of the vessel undergoing CFI measurement with a nondiabetic control
group.
Results: The two groups were exactly balanced for clinical and angiographic data. There
was no difference between CFI in the diabetic versus the non-diabetic patients (0.205 ±
0.119 and 0.217 ± 0.128; p=NS). There was still no difference in CFI when only angio-
graphically normal vessels (0.193 ± 0.084 and 0.201 ± 0.072; p=NS) or chronic total cor-
onary occlusions (0.314 ± 0.151 and 0.323 ± 0.186; p=NS) were compared. There was a
trend towards a lower number of patients having angina pectoris during the one-minute
vessel occlusion in the diabetic group (p = 0.1). There was no correlation between the
CFI and the level of HbA1c (as marker for blood glucose control over the last 2-3
months).
Conclusion: There is no difference in coronary collateral flow between diabetic and non-
diabetic patients. There is no inverse “dose-response” relation between blood glucose
control (represented by the HbA1c level) and coronary collateral flow. There is a trend
that diabetic patients have less angina pectoris during a one minute balloon occlusion
than non-diabetic patients.
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1046-165 Measurement of Resting Ankle Brachial Index May Not 
Accurately Identify Disease in Patients With Signs or 
Symptoms of Peripheral Arterial Disease
Ingrid Hriljac, Jeffrey W. Olin, Victoria Teodorescu, Susan M. Gustavson, Jonathan L. 
Halperin, Mount Sinai Medical Center, New York, NY
Background: The ankle-brachial index (ABI) is useful for objective assessment of lower
extremity arterial perfusion, correlating with symptoms and functional severity of periph-
eral arterial disease (PAD) in population-based studies. This simple, inexpensive mea-
surement can be performed in the primary care office for detection of PAD, and is a
marker of increased cardiovascular risk in both symptomatic and asymptomatic patients.
The diagnostic accuracy of the resting ABI in patients with symptoms or signs of PAD,
however, has not been determined. Methods: In order to determine the added diagnostic
utility of measuring ABI and pulse volume waveforms (PVR) at rest and after exercise, we
analyzed the results of 142 consecutive patients who were referred to the vascular labo-
ratory by non-vascular specialists between February and September 2003. Results: The
average patient age was 68 years; 54% were male. Resting ABI was normal in 44%,
abnormal in 38% and not diagnostic due to arterial calcification in 17%. Forty percent
were abnormal in those with claudication, 45% in those with ulceration and 28% in those
with rest pain. Thirty-six (57%) patients with a normal ABI underwent treadmill exercise
testing and 28% of these were found to have an abnormal exercise study indicating the
presence of PAD. Among the 24 patients (17%) with calcified vessels, 5 (21%) had
abnormal PVR consistent with PAD. Conclusion: In symptomatic patients with normal
resting ABI, PAD was diagnosed frequently by measuring ABI after exercise. Of the 17%
in whom arterial calcification precluded accurate ABI measurement, PVR disclosed PAD
in 21%. In patients with suspected PAD, referral to a vascular laboratory for exercise test-
ing and PVR offers more precise diagnosis than office measurements of ABI.
1046-166 Is the Application of Collagen-Based Vascular Closure 
Devices After Percutaneous Coronary Interventions 
Safe and Effective? Intermediate Results From the 
Prospective Bad Berka Registry
Marc-Alexander Ohlow, Hügl Burkhard, Karsten Reinig, Hubertus von Korn, Bernward 
Lauer, Zentralklinik Bad Berka, Bad Berka, Germany
Background: Several vascular closure devices (VCD) were developed as an alternative
for manual compression after percutaneous interventions (PCI) of the coronary arteries
to reduce the time to discharge. We report about the results of the collagen based VCD
VasoSeal®ES™ (Datascope Corp.) [VS] and Angio-Seal® (St. Jude Medical) [AS].
Methods: From 10/01 to 09/02 patients with collagen based VCD after percutaneous
interventions were enrolled in our prospective registry. During the intervention heparin,
aspirin and if necessary clopidogrel were administered. The two VCD were used accord-
ing to a standardized method, the choice of the device after PCI was left to the discretion
of the investigator. Secondary haemorrhage, haematomas (> 5 cm diameter), pseudoan-
eurysms and AV fistulae were noted as complications. A clinical examination and a
Duplex examination in addition was performed routinely at every patient.
Results: 5717 cardiac catheterisations were done until deadline 31.09.2002.
In 1170 cases a VCD was used after coronary intervention, 700 times AS and 470 times
VS. One of the above described complications appeared at 54 of 700 cases (7.71%) in
the AS group, in the VS group in 35 of 470 cases (7.44 %.) The predominant number of
the complications fell on minor complications such as haematoma and smaller secondary
haemorrhages (49 of 54 at AS group (7%) and 30 of 35 at VS group (6,4%). Only 5 of 54
(0,7%) of AS and in 5 of 35 (1%) of VS developed more serious complications. One
patient in the AS group developed an AV fistula, in four cases we saw pseudoaneurysms.
5 cases of the VS group developed pseudoaneurysms. All aneurysms could be success-
fully compressed in an ultrasound guided procedure. In one patient of the VS group the
